ID SSR4_HUMAN Reviewed; 388 AA. AC P31391; Q17RM1; Q17RM3; Q9UIY1; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 23-SEP-2008, sequence version 2. DT 24-JAN-2024, entry version 200. DE RecName: Full=Somatostatin receptor type 4; DE Short=SS-4-R; DE Short=SS4-R; DE Short=SS4R; DE Short=SST4; GN Name=SSTR4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-284 AND SER-321. RX PubMed=8512564; DOI=10.1006/bbrc.1993.1673; RA Xu Y., Song J., Bruno J.F., Berelowitz M.; RT "Molecular cloning and sequencing of a human somatostatin receptor, RT hSSTR4."; RL Biochem. Biophys. Res. Commun. 193:648-652(1993). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-83; VAL-284 AND RP SER-321. RX PubMed=8483934; DOI=10.1073/pnas.90.9.4196; RA Rohrer L., Raulf F., Bruns C., Buettner R., Hofstaedter F., Schuele R.; RT "Cloning and characterization of a fourth human somatostatin receptor."; RL Proc. Natl. Acad. Sci. U.S.A. 90:4196-4200(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8373420; DOI=10.1006/bbrc.1993.2122; RA Yamada Y., Kagimoto S., Kubota A., Yasuda K., Masuda K., Someya Y., RA Ihara Y., Li Q., Imura H., Seino S., Seino Y.; RT "Cloning, functional expression and pharmacological characterization of a RT fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype."; RL Biochem. Biophys. Res. Commun. 195:844-852(1993). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8100352; RA Demchyshyn L.L., Srikant C.B., Sunahara R.K., Kent G., Seeman P., RA van Tol H.H.M., Panetta R., Patel Y.C., Niznik H.B.; RT "Cloning and expression of a human somatostatin-14-selective receptor RT variant (somatostatin receptor 4) located on chromosome 20."; RL Mol. Pharmacol. 43:894-901(1993). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-284 AND SER-321. RA Kopatz S.A., Aronstam R.S., Sharma S.V.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=11780052; DOI=10.1038/414865a; RA Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., RA Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., RA Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., RA Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D., RA Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G., RA Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E., RA Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D., RA Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., RA Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., RA Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., RA Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., RA Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., RA Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., RA Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., RA Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., RA Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., RA Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M., RA Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D., RA Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M., RA Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A., RA Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L., RA Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L., RA Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 20."; RL Nature 414:865-871(2001). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-284 AND SER-321. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Receptor for somatostatin-14. The activity of this receptor CC is mediated by G proteins which inhibits adenylyl cyclase. It is CC functionally coupled not only to inhibition of adenylate cyclase, but CC also to activation of both arachidonate release and mitogen-activated CC protein (MAP) kinase cascade. Mediates antiproliferative action of CC somatostatin in tumor cells. CC -!- INTERACTION: CC P31391; P35346: SSTR5; NbExp=3; IntAct=EBI-21274002, EBI-27053622; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Specifically expressed in fetal and adult brain, CC lung tissue, stomach, and in lesser quantities in the kidney, pituitary CC and adrenals. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D16826; BAA04106.1; -; Genomic_DNA. DR EMBL; L14856; AAA36623.1; -; Genomic_DNA. DR EMBL; L07833; AAA60565.1; -; Genomic_DNA. DR EMBL; L07061; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AY548169; AAS55648.1; -; Genomic_DNA. DR EMBL; AL049651; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471133; EAX10170.1; -; Genomic_DNA. DR EMBL; BC069063; AAH69063.1; -; mRNA. DR EMBL; BC117270; AAI17271.1; -; mRNA. DR EMBL; BC117272; AAI17273.1; -; mRNA. DR CCDS; CCDS42856.1; -. DR PIR; JN0605; JN0605. DR RefSeq; NP_001043.2; NM_001052.2. DR PDB; 7XMS; EM; 2.90 A; R=2-328. DR PDB; 7XMT; EM; 2.80 A; R=2-328. DR PDBsum; 7XMS; -. DR PDBsum; 7XMT; -. DR AlphaFoldDB; P31391; -. DR EMDB; EMD-33303; -. DR EMDB; EMD-33304; -. DR SMR; P31391; -. DR BioGRID; 112632; 5. DR CORUM; P31391; -. DR IntAct; P31391; 4. DR STRING; 9606.ENSP00000255008; -. DR BindingDB; P31391; -. DR ChEMBL; CHEMBL1853; -. DR DrugBank; DB13985; Lutetium Lu 177 dotatate. DR DrugBank; DB09099; Somatostatin. DR DrugCentral; P31391; -. DR GuidetoPHARMACOLOGY; 358; -. DR GlyCosmos; P31391; 1 site, No reported glycans. DR GlyGen; P31391; 1 site. DR iPTMnet; P31391; -. DR PhosphoSitePlus; P31391; -. DR BioMuta; SSTR4; -. DR DMDM; 206729897; -. DR MassIVE; P31391; -. DR PaxDb; 9606-ENSP00000255008; -. DR PeptideAtlas; P31391; -. DR Antibodypedia; 20974; 279 antibodies from 33 providers. DR DNASU; 6754; -. DR Ensembl; ENST00000255008.5; ENSP00000255008.3; ENSG00000132671.6. DR GeneID; 6754; -. DR KEGG; hsa:6754; -. DR MANE-Select; ENST00000255008.5; ENSP00000255008.3; NM_001052.4; NP_001043.2. DR UCSC; uc002wsr.3; human. DR AGR; HGNC:11333; -. DR CTD; 6754; -. DR DisGeNET; 6754; -. DR GeneCards; SSTR4; -. DR HGNC; HGNC:11333; SSTR4. DR HPA; ENSG00000132671; Not detected. DR MIM; 182454; gene. DR neXtProt; NX_P31391; -. DR OpenTargets; ENSG00000132671; -. DR PharmGKB; PA36157; -. DR VEuPathDB; HostDB:ENSG00000132671; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT00940000156819; -. DR HOGENOM; CLU_009579_8_1_1; -. DR InParanoid; P31391; -. DR OMA; AIQCIYA; -. DR OrthoDB; 5393360at2759; -. DR PhylomeDB; P31391; -. DR TreeFam; TF315737; -. DR PathwayCommons; P31391; -. DR Reactome; R-HSA-375276; Peptide ligand-binding receptors. DR Reactome; R-HSA-418594; G alpha (i) signalling events. DR SignaLink; P31391; -. DR SIGNOR; P31391; -. DR BioGRID-ORCS; 6754; 15 hits in 1140 CRISPR screens. DR GeneWiki; Somatostatin_receptor_4; -. DR GenomeRNAi; 6754; -. DR Pharos; P31391; Tclin. DR PRO; PR:P31391; -. DR Proteomes; UP000005640; Chromosome 20. DR RNAct; P31391; Protein. DR Bgee; ENSG00000132671; Expressed in prefrontal cortex and 20 other cell types or tissues. DR GO; GO:0043005; C:neuron projection; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central. DR GO; GO:0004994; F:somatostatin receptor activity; IBA:GO_Central. DR GO; GO:0016477; P:cell migration; IEA:Ensembl. DR GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IBA:GO_Central. DR GO; GO:0030900; P:forebrain development; IEA:Ensembl. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc. DR GO; GO:0106072; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; IEA:Ensembl. DR GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc. DR GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central. DR GO; GO:0090238; P:positive regulation of arachidonic acid secretion; IEA:Ensembl. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl. DR CDD; cd15973; 7tmA_SSTR4; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR000586; Somatstn_rcpt. DR InterPro; IPR001512; Somatstn_rcpt_4. DR PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1. DR PANTHER; PTHR24229:SF35; SOMATOSTATIN RECEPTOR TYPE 4; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR00246; SOMATOSTATNR. DR PRINTS; PR00590; SOMATOSTTN4R. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P31391; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor; KW Glycoprotein; Lipoprotein; Membrane; Palmitate; Receptor; KW Reference proteome; Transducer; Transmembrane; Transmembrane helix. FT CHAIN 1..388 FT /note="Somatostatin receptor type 4" FT /id="PRO_0000070127" FT TOPO_DOM 1..46 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 47..73 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 74..83 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 84..104 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 105..120 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 121..142 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 143..161 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 162..185 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 186..208 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 209..232 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 233..260 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 261..280 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 281..291 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 292..314 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 315..388 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT LIPID 327 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT CARBOHYD 24 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 119..198 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT VARIANT 83 FT /note="N -> T (in dbSNP:rs1065191)" FT /evidence="ECO:0000269|PubMed:8483934" FT /id="VAR_011703" FT VARIANT 236 FT /note="G -> D (in dbSNP:rs35601930)" FT /id="VAR_049441" FT VARIANT 284 FT /note="F -> V (in dbSNP:rs3746726)" FT /evidence="ECO:0000269|PubMed:15489334, FT ECO:0000269|PubMed:8483934, ECO:0000269|PubMed:8512564, FT ECO:0000269|Ref.5" FT /id="VAR_021560" FT VARIANT 321 FT /note="F -> S (in dbSNP:rs2567608)" FT /evidence="ECO:0000269|PubMed:15489334, FT ECO:0000269|PubMed:8483934, ECO:0000269|PubMed:8512564, FT ECO:0000269|Ref.5" FT /id="VAR_021561" FT CONFLICT 365 FT /note="P -> K (in Ref. 2; AAA60565)" FT /evidence="ECO:0000305" FT HELIX 47..73 FT /evidence="ECO:0007829|PDB:7XMT" FT TURN 74..76 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 81..96 FT /evidence="ECO:0007829|PDB:7XMT" FT TURN 97..99 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 100..108 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 119..149 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 151..154 FT /evidence="ECO:0007829|PDB:7XMT" FT TURN 155..157 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 160..178 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 180..183 FT /evidence="ECO:0007829|PDB:7XMT" FT STRAND 184..187 FT /evidence="ECO:0007829|PDB:7XMS" FT STRAND 191..194 FT /evidence="ECO:0007829|PDB:7XMS" FT STRAND 198..200 FT /evidence="ECO:0007829|PDB:7XMS" FT HELIX 205..217 FT /evidence="ECO:0007829|PDB:7XMT" FT TURN 218..220 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 221..244 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 252..283 FT /evidence="ECO:0007829|PDB:7XMT" FT TURN 287..290 FT /evidence="ECO:0007829|PDB:7XMS" FT HELIX 294..306 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 308..311 FT /evidence="ECO:0007829|PDB:7XMT" FT STRAND 313..315 FT /evidence="ECO:0007829|PDB:7XMT" FT HELIX 316..319 FT /evidence="ECO:0007829|PDB:7XMT" SQ SEQUENCE 388 AA; 42003 MW; DFCD9393620EDFC9 CRC64; MSAPSTLPPG GEEGLGTAWP SAANASSAPA EAEEAVAGPG DARAAGMVAI QCIYALVCLV GLVGNALVIF VILRYAKMKT ATNIYLLNLA VADELFMLSV PFVASSAALR HWPFGSVLCR AVLSVDGLNM FTSVFCLTVL SVDRYVAVVH PLRAATYRRP SVAKLINLGV WLASLLVTLP IAIFADTRPA RGGQAVACNL QWPHPAWSAV FVVYTFLLGF LLPVLAIGLC YLLIVGKMRA VALRAGWQQR RRSEKKITRL VLMVVVVFVL CWMPFYVVQL LNLFVTSLDA TVNHVSLILS YANSCANPIL YGFLSDNFRR FFQRVLCLRC CLLEGAGGAE EEPLDYYATA LKSKGGAGCM CPPLPCQQEA LQPEPGRKRI PLTRTTTF //